Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

计划入组 24 人 · 首次发布于 2009 年 5 月 28 日

Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

计划入组 300 人 · 首次发布于 2013 年 3 月 1 日

3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA

首次发布于 2015 年 5 月 12 日

T cell receptors natural killer T-cells therapy (Athenex)

Chimeric Natural Killer Receptor-Universal T Cells therapy(Fujian Medical University)

Allogeneic natural killer cells

STEM CELLS ARABIA

Jordan

Personalized Stem Cells, Inc.

United States

KLSMC Stem Cells, Inc.

MiNK Therapeutics Reports Clinical Progress with iNKT Cell Therapy, Targets Phase II Gastric Cancer Data by End of 2025

CancerVax Announces Promising New Drug to Treat a Deadly Children's Cancer

ImmunityBio Secures $100 Million in Financing to Support Global Expansion of ANKTIVA Immunotherapy